SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-19-000582
Filing Date
2019-01-02
Accepted
2019-01-02 16:05:35
Documents
1
Group Members
SV LIFE SCIENCES FUND VI (GP), L.P.SV LIFE SCIENCES FUND VI STRATEGIC PARTNERS, L.P.SV LIFE SCIENCES FUND VI, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d657284dsc13da.htm SC 13D/A 78151
  Complete submission text file 0001193125-19-000582.txt   79967
Mailing Address 500 TOTTEN POND ROAD WALTHAM MA 02451
Business Address 500 TOTTEN POND ROAD WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Subject) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90130 | Film No.: 19501687
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O SV HEALTH INVESTORS, LLC ONE BOSTON PLC, 201 WASHINGTON ST. #3900 BOSTON MA 02108
Business Address C/O SV HEALTH INVESTORS, LLC ONE BOSTON PLC, 201 WASHINGTON ST. #3900 BOSTON MA 02108 6173678100
SVLSF VI, LLC (Filed by) CIK: 0001717728 (see all company filings)

IRS No.: 473729692 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A